Serial SPAC sponsor Chamath Palihapitiya is teaming up with the head of a little known hedge fund that has enjoyed the most successful new launch in recent memory.
The pair disclosed plans to launch no fewer than four blank check companies seeking to do deals in the biotech industry in a series of regulatory filings made public on Wednesday evening.
